The U.S. Meals and Drug Administration has cleared the Signos Glucose Monitoring System, an over-the-counter glucose monitoring system for weight administration.
Signos integrates the Stelo by Dexcom glucose biosensor with a man-made intelligence-driven platform to point out how meals, exercise, stress, sleep, and timing have an effect on the physique in actual time—empowering folks to make personalised, biology-backed well being selections.
Key options of the monitoring system embody personalised metabolic steerage that makes use of the physique’s personal indicators and synthetic intelligence-driven insights to assist customers enhance sleep, handle weight, and decrease power illness danger. The system interprets real-time glucose fluctuations into easy, personalised suggestions for more healthy every day habits and tracks and connects responses to meals, train, sleep, and stress.
Clients can subscribe to Signos with a three-month plan for $139 per 30 days or a six-month plan for $129 per 30 days. The corporate gives all crucial steady glucose screens for the chosen plan length.
In accordance with the U.S. Facilities for Illness Management and Prevention, 73.6% of U.S. adults are categorised as having chubby or weight problems. With the outcomes of the World Burden of Illness Examine 2021 projecting diabetes diagnoses will attain 1.3 billion by 2050, the dimensions of the metabolic well being disaster is quickly accelerating.
“This is more than a product launch—it’s a mission,” Sharam Fouladgar-Mercer, CEO and founding father of Signos, stated in a press release. “Everyone deserves access to insights that help them live healthier, longer, more vibrant lives. Signos isn’t just about data; it’s about giving people ownership over their health and weight journeys in a way never before seen.”
Quotation:
FDA clears OTC glucose monitoring system for weight administration (2025, August 25)
retrieved 25 August 2025
from https://medicalxpress.com/information/2025-08-fda-otc-glucose-weight.html
This doc is topic to copyright. Aside from any truthful dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.
